Vantage Consulting Group Inc Bristol Myers Squibb CO Transaction History

Vantage Consulting Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $49,749 - $65,495	1,236 Added 27.97%	5,655 $234,000
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $11,179 - $12,675	-233 Reduced 5.01%	4,419 $239,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $40,917 - $48,825	844 Added 22.16%	4,652 $238,000
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $14,935 - $16,700	258 Added 7.27%	3,808 $221,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $6,243 - $6,932	-98 Reduced 2.69%	3,550 $227,000
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $37,848 - $42,929	576 Added 18.75%	3,648 $252,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $40,403 - $47,843	-590 Reduced 16.11%	3,072 $220,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $59 - $34,885	454 Added 14.15%	3,662 $260,000
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $9,222 - $10,157	-127 Reduced 3.81%	3,208 $247,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $78,755 - $94,435	-1,281 Reduced 27.75%	3,335 $244,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $40,973 - $47,765	764 Added 19.83%	4,616 $288,000
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $28,756 - $33,684	486 Added 14.44%	3,852 $228,000
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $208,389 - $226,935	3,366 New	3,366 $225,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $71,267 - $80,154	-1,201 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $69,345 - $78,581	1,201 New	1,201 $74,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vantage Consulting Group Inc with notifications on news.